An overview of phase I/II studies of SU101, a tyrosine kinase inhibitor, in patients with recurrent malignant glioma and advanced solid tumors Meeting Abstract


Authors: Hannah, A.; Malkin, M.; Rosen, L.; Lopez, A. M.; Marshall, J.; Lombardi, C. C.; Eckhardt, S. G.
Abstract Title: An overview of phase I/II studies of SU101, a tyrosine kinase inhibitor, in patients with recurrent malignant glioma and advanced solid tumors
Meeting Title: 10th NCI-EORTC Symposium on New Drugs in Cancer Therapy
Journal Title: Annals of Oncology
Volume: 9
Issue: Suppl. 2
Meeting Dates: 1998 Jun 16-19
Meeting Location: Amsterdam, Netherlands
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 1998-05-01
Start Page: 18
End Page: 19
Language: English
ACCESSION: WOS:000074749600055
PROVIDER: wos
PUBMED: 9781244
Notes: Meeting Abstract: 052 -- Source: Wos
Citation Impact
MSK Authors
  1. Mark Malkin
    38 Malkin